1 – 10 of 21
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Psychiatry Nurses' Experiences of Patient-Initiated Brief Admission from Inpatient and Outpatient Perspectives : A Qualitative Exploratory Study
(
- Contribution to journal › Article
- 2014
-
Mark
Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro.
(
- Contribution to journal › Article
- 2010
-
Mark
Development of a C5AR antagonist for the treatment of reperfusion injury
2010) 8th Joint Conference of the International-Cytokine-Society/International-Society-for-and-Cytokine-Re search In Cytokine 52(1-2). p.26-26(
- Contribution to journal › Published meeting abstract
-
Mark
Directed evolution of chemotaxis inhibitory protein of Staphylococcus aureus generates biologically functional variants with reduced interaction with human antibodies
(
- Contribution to journal › Article
- 2009
-
Mark
Molecular evolution of a C5aR antagonist against inflammatory disease
2009)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Purification of truncated and mutated chemotaxis inhibitory protein of Staphylococcus aureus—an anti-inflammatory protein
(
- Contribution to journal › Article
-
Mark
Identification of conformational epitopes for human IgG on chemotaxis inhibitory protein of Staphylococcus aureus
(
- Contribution to journal › Article
- 2008
-
Mark
Serum response factor is required for sprouting angiogenesis and vascular integrity
(
- Contribution to journal › Article
-
Mark
Perlecan is critical for heart stability
(
- Contribution to journal › Article